These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 31631716)

  • 41. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.
    Casanova C; Celli BR; de-Torres JP; Martínez-Gonzalez C; Cosio BG; Pinto-Plata V; de Lucas-Ramos P; Divo M; Fuster A; Peces-Barba G; Calle-Rubio M; Solanes I; Aguero R; Feu-Collado N; Alfageme I; De Diego A; Romero A; Balcells E; Llunell A; Galdiz JB; Marin M; Moreno A; Cabrera C; Golpe R; Lacarcel C; Soriano JB; López-Campos JL; Soler-Cataluña JJ; Marin JM
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29167301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Pignatti P; Visca D; Cherubino F; Zampogna E; Lucini E; Saderi L; Sotgiu G; Spanevello A
    Respir Res; 2019 Jul; 20(1):145. PubMed ID: 31291952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peak flow variability and sputum eosinophilia in allergic rhinitis.
    Gutiérrez V; Prieto L; Torres V; Morales C; González E
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):143-50. PubMed ID: 9723560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.
    Soter S; Barta I; Antus B
    Inflammation; 2013 Oct; 36(5):1178-85. PubMed ID: 23681903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
    Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
    Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of the role of blood eosinophil count in patients with severe acute exacerbation of chronic obstructive pulmonary disease hospitalized in a Tunisian Center].
    Saad AB; Khemakhem R; Mhamed SC; Fahem N; Migaou A; Joobeur S; Rouatbi N
    Pan Afr Med J; 2019; 34():138. PubMed ID: 33708307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Airway inflammation and hyperresponsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease.
    Rutgers SR; Timens W; Tzanakis N; Kauffman HF; van der Mark TW; Koëter GH; Postma DS
    Clin Exp Allergy; 2000 May; 30(5):657-62. PubMed ID: 10792357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD.
    Ronchi MC; Piragino C; Rosi E; Amendola M; Duranti R; Scano G
    Thorax; 1996 Oct; 51(10):1000-4. PubMed ID: 8977600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction in bronchodilation following a deep inhalation is poorly related to airway inflammation in asthma.
    Pacini F; Filippelli M; Duranti R; Rosi E; Romagnoli I; Grazzini M; Stendardi L; Misuri G; Scano G
    Eur Respir J; 1999 Nov; 14(5):1055-60. PubMed ID: 10596690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood Count of Eosinophil Polymorphonuclear Leucocytes and Bronchial Hyperreactivity in Chronic Obstructive Pulmonary Disease.
    Cukic V
    Med Arch; 2017 Oct; 71(5):347-350. PubMed ID: 29284904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD.
    Saha S; Doe C; Mistry V; Siddiqui S; Parker D; Sleeman M; Cohen ES; Brightling CE
    Thorax; 2009 Aug; 64(8):671-6. PubMed ID: 19213775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis.
    Rosi E; Ronchi MC; Grazzini M; Duranti R; Scano G
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):232-7. PubMed ID: 9949313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are sputum eosinophils associated with a different phenotype in COPD patients? A retrospective study.
    Bartoli ML; Latorre M; Vagaggini B; Nieri D; Cianchetti S; Di Franco A; Celi A; Paggiaro P
    Respir Med; 2021 Dec; 190():106672. PubMed ID: 34801800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
    Greulich T; Tüffers J; Mager S; Eder A; Maxheim M; Alter P; Schmeck B; Vogelmeier CF
    Respir Res; 2020 May; 21(1):106. PubMed ID: 32375777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD.
    Nakamura S; Wakahara K; Majima S; Yokoi E; Fukutani E; Otsuki R; Iwano S; Chen-Yoshikawa TF; Kinoshita F; Abe T; Sashio T; Kimura T; Izuhara K; Hashimoto N; Ishii M; Hasegawa Y
    BMC Pulm Med; 2024 Oct; 24(1):510. PubMed ID: 39396940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study.
    Serafino-Agrusa L; Scichilone N; Spatafora M; Battaglia S
    Pulm Pharmacol Ther; 2016 Apr; 37():89-94. PubMed ID: 26996272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship between airway immunoglobulin activity and eosinophils in COPD.
    Southworth T; Higham A; Kolsum U; Li J; Scott T; Dungwa J; Sridhar S; Pham TH; Newbold P; Singh D
    J Cell Mol Med; 2021 Feb; 25(4):2203-2212. PubMed ID: 33369092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.